Findings

What do systematic reviews say?

38 questions · 38 findings · 20 reviews · Headline outcomes only

Sort:Best matchNewest Highest certainty Download CSV

No studies found 17 · 44.7%GRADE not reported 17 · 44.7%Very low 1 · 2.6%Low 3 · 7.9%Moderate 0 · 0%High 0 · 0%

Aspirin plus antipsychotics vs placebo/no adjunctive treatment + antipsychotics

Quality of life: clinically important change in quality of life · patients with schizophrenia

The review found no eligible studies for this question.

1 finding from 1 review

Acetylsalicylic acid (aspirin) for schizophrenia 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Mirtazapine adjunct vs placebo adjunct

Quality of life: clinically important change in quality of life · schizophrenia

The review found no eligible studies for this question.

1 finding from 1 review

Mirtazapine adjunct for people with schizophrenia 2018 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Yoga package vs usual care

Quality of life: clinically important change in quality of life · patients with schizophrenia

1 finding from 1 review

Yoga as part of a package of care versus standard care for schizophrenia 2017 · Cochrane Headline outcomes only
no estimate extracted
1 study · 80 participants
Low

Interventions for vs no intervention

Quality of life: clinically important change in quality of life · cases of SUDEP and matched controls (number of deaths due to SUDEP) and consecutive people with epilepsy from a tertiary care teaching…

1 finding from 1 review

Treatments for the prevention of Sudden Unexpected Death in Epilepsy (SUDEP) 2020 · Cochrane Headline outcomes only
no estimate extracted
215 participants
Very low

Magnetic seizure therapy plus standard care vs electroconvulsive therapy plus standard care

Quality of life: clinically important change ‐ not measured · people with the acute phase of schizophrenia

The review found no eligible studies for this question.

1 finding from 1 review

Magnetic seizure therapy for people with schizophrenia 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings table ‐ Continuation vs reduction of polypharmacy

Quality of life: clinically important change ‐ not measured · patients with schizophrenia

The review found no eligible studies for this question.

1 finding from 1 review

Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Haloperidol discontinuation vs haloperidol continuation

Quality of life: clinically important change in quality of life · schizophrenia

The review found no eligible studies for this question.

1 finding from 1 review

Haloperidol discontinuation for people with schizophrenia 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Omega‐3 vs placebo

Quality of life: clinically important change in quality of life · people in the prodromal stage of psychosis

1 finding from 1 review

Interventions for prodromal stage of psychosis 2019 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Group B antipsychotic drugs: amisulpiride + needs‐focused intervention vs needs‐focused intervention

Quality of life: clinically important change in quality of life · people in the prodromal stage of psychosis

1 finding from 1 review

Interventions for prodromal stage of psychosis 2019 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Group B antipsychotic drugs: olanzapine + supportive intervention vs placebo or supportive treatment

Quality of life: clinically important change in quality of life · people in the prodromal stage of psychosis

1 finding from 1 review

Interventions for prodromal stage of psychosis 2019 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Group A: amino acids vs placebo

Quality of life: clinically important change in quality of life · people in the prodromal stage of psychosis

1 finding from 1 review

Interventions for prodromal stage of psychosis 2019 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Group C cognitive behavioural therapy: cognitive behavioural therapy + supportive intervention vs non‐directive reflective listening + supportive intervention

Quality of life: clinically important change in quality of life · people in the prodromal stage of psychosis

1 finding from 1 review

Interventions for prodromal stage of psychosis 2019 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Cognitive training vs active control

Quality of life: clinically important change in quality of life · people in the prodromal stage of psychosis

1 finding from 1 review

Interventions for prodromal stage of psychosis 2019 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Group C other: family treatment vs enhanced care

Quality of life: clinically important change in quality of life · people in the prodromal stage of psychosis

1 finding from 1 review

Interventions for prodromal stage of psychosis 2019 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Group C other: integrated treatment vs usual care

Quality of life: clinically important change in quality of life · people in the prodromal stage of psychosis

1 finding from 1 review

Interventions for prodromal stage of psychosis 2019 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

ACUPUNCTURE added to LOW DOSE ANTIPSYCHOTICS vs STANDARD DOSE ANTIPSYCHOTICS

Quality of life: No clinically important change in quality of life · patients with schizophrenia

The review found no eligible studies for this question.

1 finding from 1 review

Acupuncture for schizophrenia 2014 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Acupuncture vs STANDARD DOSE ANTIPSYCHOTICS

Quality of life: No clinically important change in quality of life · patients with schizophrenia

The review found no eligible studies for this question.

1 finding from 1 review

Acupuncture for schizophrenia 2014 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

ACUPUNCTURE added to TCM DRUG vs TCM DRUG

Quality of life: No clinically important change in quality of life · patients with schizophrenia

The review found no eligible studies for this question.

1 finding from 1 review

Acupuncture for schizophrenia 2014 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Acupuncture vs TCM DRUG

Quality of life: No clinically important change in quality of life · patients with schizophrenia

The review found no eligible studies for this question.

1 finding from 1 review

Acupuncture for schizophrenia 2014 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

ELECTRIC ACUPUNCTURE CONVULSIVE THERAPY vs ECT

Quality of life: No clinically important change in quality of life · patients with schizophrenia

The review found no eligible studies for this question.

1 finding from 1 review

Acupuncture for schizophrenia 2014 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found